谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

Erratum to “rondeau E, Scully M, Ariceta G, Barbour T, Cataland S, Heyne N, Miyakawa Y, Ortiz S, Swenson E, Vallee M, Yoon S-S, Kavanagh D, Haller H; on Behalf of the 311 Study Group. the Long-Acting C5 Inhibitor, Ravulizumab, is Effective and Safe in Adult Patients with Atypical Hemolytic Uremic Syndrome Naïve to Complement Inhibitor Treatment” Kidney Int. 2020;97:1287–1296

Eric Rondeau,Marie Scully,Gema Ariceta,Tom Barbour,Spero Cataland,Nils Heyne,Yoshitaka Miyakawa,Stephan Ortiz, Eugene Swenson,Marc Vallee,Sung-Soo Yoon,David Kavanagh,Hermann Haller,Sunil Babu,Nilufer Broeders, Nicole Lietar, Fiona Brown,Philip Campbell,Paramit Chowdhury, Theo Kasimatis,Lino Cirami,Leonardo Caroti, Guilia Antognoli,Yahsou Delmas,Vladimir Dobronravov,Anja Gaeckler,Cyril Garrouste, Gregory Greenwood,Siân Griffin, Chiu-Ching Huang,I-Ru Chen, Susan Huang,Jin Seok Kim, Gaetano La Manna,Giorgia Comai,Maria Cappuccilli, Moglie Le Quintrec, Guillaume Jeantet, Iino Fumie,Yosu Luque, Jan Menne, Johan Morelle,Eric Goffin,Anja Muhlfeld, Shashi Nagaraj, Gowthami Arepally, Doyeun Oh, Masayoshi Okumi,Manuel Praga Terente, Elena Gutierréz, Paola Rodriguez,Francois Provot, Ulf Schönermarck,Michael Fischereder, Natalia Ramos Terrada,Barbara Seitz-Polski,Guillaume Favre,Sonia Boyer-Suavet,Maria Vinogradova,Tatiana Kirsanova,Edwin K.S. Wong

Kidney International（2020）

引用 1|浏览1
暂无评分
关键词
Hemolytic Uremic Syndrome
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要